Literature DB >> 11682057

Role of Flk-1 in mouse hematopoietic stem cells.

H Haruta1, Y Nagata, K Todokoro.   

Abstract

It was reported that human hematopoietic stem cells in bone marrow were restricted to the CD34(+)KDR(+) cell fraction. We found that expression levels of Flk-1, a mouse homologue of KDR, were low or undetectable in mouse Lin(-)c-Kit(+)Sca-1(+)CD34(low/-) cells as well as Hoechst33342(-) cells (side population), which have long-term reconstitution capacity. Furthermore, neither Flk-1(+)CD34(low/-) cells nor Flk-1(+)CD34(+) cells had long-term reconstitution capacity in mouse. Taken together with other observations using Flk-1-deficient mice, these results indicate that Flk-1 is essential for the development of hematopoietic stem cells in embryo but not for the function of hematopoietic stem cells in adult mouse bone marrow.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11682057     DOI: 10.1016/s0014-5793(01)02921-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

1.  Hematopoietic stem cells do not engraft with absolute efficiencies.

Authors:  Fernando D Camargo; Stuart M Chambers; Erin Drew; Kelly M McNagny; Margaret A Goodell
Journal:  Blood       Date:  2005-10-04       Impact factor: 22.113

2.  HIF prolyl hydroxylase inhibitor FG-4497 enhances mouse hematopoietic stem cell mobilization via VEGFR2/KDR.

Authors:  Kavita Bisht; Marion E Brunck; Taichi Matsumoto; Crystal McGirr; Bianca Nowlan; Whitney Fleming; Thomas Keech; Graham Magor; Andrew C Perkins; Julie Davies; Gail Walkinshaw; Lee Flippin; Ingrid G Winkler; Jean-Pierre Levesque
Journal:  Blood Adv       Date:  2019-02-12

3.  Distinct roles of VEGFR-1 and VEGFR-2 in the aberrant hematopoiesis associated with elevated levels of VEGF.

Authors:  Yuhui Huang; Xiaolan Chen; Mikhail M Dikov; Sergey V Novitskiy; Claudio A Mosse; Li Yang; David P Carbone
Journal:  Blood       Date:  2007-03-21       Impact factor: 22.113

4.  Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment.

Authors:  Koichi Hattori; Beate Heissig; Yan Wu; Sergio Dias; Rafael Tejada; Barbara Ferris; Daniel J Hicklin; Zhenping Zhu; Peter Bohlen; Larry Witte; Jan Hendrikx; Neil R Hackett; Ronald G Crystal; Malcolm A S Moore; Zena Werb; David Lyden; Shahin Rafii
Journal:  Nat Med       Date:  2002-07-01       Impact factor: 53.440

Review 5.  The role of VEGF in normal and neoplastic hematopoiesis.

Authors:  Hans-Peter Gerber; Napoleone Ferrara
Journal:  J Mol Med (Berl)       Date:  2002-12-14       Impact factor: 4.599

6.  Role of VEGF in organogenesis.

Authors:  Jody J Haigh
Journal:  Organogenesis       Date:  2008-10       Impact factor: 2.500

7.  sMEK1 inhibits endothelial cell proliferation by attenuating VEGFR-2-dependent-Akt/eNOS/HIF-1α signaling pathways.

Authors:  Boh-Ram Kim; Seung Hee Seo; Mi Sun Park; Seung-Hoon Lee; Youngjoo Kwon; Seung Bae Rho
Journal:  Oncotarget       Date:  2015-10-13

Review 8.  Methods to label, image, and analyze the complex structural architectures of microvascular networks.

Authors:  Bruce A Corliss; Corbin Mathews; Richard Doty; Gustavo Rohde; Shayn M Peirce
Journal:  Microcirculation       Date:  2019-01-17       Impact factor: 2.628

9.  Engraftment and reconstitution of hematopoiesis is dependent on VEGFR2-mediated regeneration of sinusoidal endothelial cells.

Authors:  Andrea T Hooper; Jason M Butler; Daniel J Nolan; Andrea Kranz; Kaoruko Iida; Mariko Kobayashi; Hans-Georg Kopp; Koji Shido; Isabelle Petit; Kilangsungla Yanger; Daylon James; Larry Witte; Zhenping Zhu; Yan Wu; Bronislaw Pytowski; Zev Rosenwaks; Vivek Mittal; Thomas N Sato; Shahin Rafii
Journal:  Cell Stem Cell       Date:  2009-03-06       Impact factor: 24.633

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.